Netherlands Healthcare Diagnostics Market Size- By Product Type, By Application, By End-User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Description

Introduction and Overview

The pandemic put a strain on resources, which caused delays in non-emergency treatments and diagnoses in many healthcare systems. The pandemic affected the availability of diagnostic tools, reagents, and other necessary components by upsetting international supply systems. This might have had an impact on the market for medical diagnostics in the Netherlands.

The process of determining an individual's illness, condition, or infection by a variety of tests, procedures, and technologies is known as healthcare diagnostics. In the medical field, the main objective of diagnostic testing is to gather data regarding an individual's health status in order to support illness prevention, diagnosis, and treatment. Because they give medical personnel vital information about a patient's state, diagnostic procedures are important in helping them make decisions about their care.

Scope of the Report

Report Metric Details:

Market size available for years: 2019-2033

Base year considered: 2022

Forecast period: 2023-2033

Segments covered: By Product Type, By Application, By End-User

Regions covered: Amsterdam Metropolitan Area, Eindhoven Region, Flevoland, Gelderland, North Brabant, North Holland, Rotterdam, South Holland, Utrecht Region, Zeeland

Companies Covered: Fresenius SE & Co., Siemens Healthineers, GE Healthcare, Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics and various others.

Key Segments Covered:

By Application: Based on the Application, Netherlands Healthcare Diagnostics Market is segmented as; Autoimmune Disease, Cardiology, Diabetes, Infectious Diseases, Oncology and Others.

By End-User: Based on the End-User, Netherlands Healthcare Diagnostics Market is segmented as; Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Other End Users.

By Region: This research also includes data for Amsterdam Metropolitan Area, Eindhoven Region, Flevoland, Gelderland, North Brabant, North Holland, Rotterdam, South Holland, Utrecht Region, and Zeeland.

Product Code: HLCA2380

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
4.2. COVID-19 Impacts of the Netherlands Healthcare Diagnostics Market

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Netherlands Healthcare Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Netherlands Healthcare Diagnostics Market

7. Netherlands Healthcare Diagnostics Market, By Product Type (USD Million)

7.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Product Type, 2023-2033
7.2. Instruments
7.3. Reagents
7.4. Other Products

8. Netherlands Healthcare Diagnostics Market, By Application (USD Million)

8.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Product Type, 2023-2033
8.2. Autoimmune Disease
8.3. Cardiology
8.4. Diabetes
8.5. Infectious Diseases
8.6. Oncology
8.7. Others

9. Netherlands Healthcare Diagnostics Market, By End-User (USD Million)

9.1. Netherlands Healthcare Diagnostics Market Value Share and Forecast, By Distribution Channel, 2023-2033
9.2. Diagnostic Laboratory
9.3. Hospital Laboratory
9.4. Point-of-care Testing
9.5. Other End Users

10. Netherlands Healthcare Diagnostics Market Forecast, 2019-2033 (USD Million)

10.1. Netherlands Healthcare Diagnostics Market Size and Market Share

11. Netherlands Healthcare Diagnostics Market, By Product Type, 2019-2033 (USD Million)

11.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Product Type (2019-2026)
11.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Product Type (2027-2033)

12. Netherlands Healthcare Diagnostics Market, By Application , 2019-2033 (USD Million)

12.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Application (2019-2026)
12.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Application (2027-2033)

13. Netherlands Healthcare Diagnostics Market, By End-User , 2019-2033 (USD Million)

13.1. Netherlands Healthcare Diagnostics Market Size and Market Share By End-User (2019-2026)
13.2. Netherlands Healthcare Diagnostics Market Size and Market Share By End-User (2027-2033)

14. Netherlands Healthcare Diagnostics Market, By Region, 2019-2033 (USD Million)

14.1. Netherlands Healthcare Diagnostics Market Size and Market Share By Region (2019-2026)
14.2. Netherlands Healthcare Diagnostics Market Size and Market Share By Region (2027-2033)
14.3. Netherlands
- 14.3.1. Amsterdam Metropolitan Area
- 14.3.2. Eindhoven Region
- 14.3.3. Flevoland
- 14.3.4. Gelderland
- 14.3.5. North Brabant
- 14.3.6. North Holland
- 14.3.7. Rotterdam
- 14.3.8. South Holland
- 14.3.9. Utrecht Region
- 14.3.10. Zeeland

15. Company Profile

15.1. Abbott Laboratories
- 15.1.1. Company details
- 15.1.2. Financial outlook
- 15.1.3. Product summary
- 15.1.4. Recent developments
15.2. Becton
- 15.2.1. Company details
- 15.2.2. Financial outlook
- 15.2.3. Product summary
- 15.2.4. Recent developments
15.3. Bio-Rad Laboratories Inc.
- 15.3.1. Company details
- 15.3.2. Financial outlook
- 15.3.3. Product summary
- 15.3.4. Recent developments
15.4. Danaher Corporation
- 15.4.1. Company details
- 15.4.2. Financial outlook
- 15.4.3. Product summary
- 15.4.4. Recent developments
15.5. Fresenius SE & Co
- 15.5.1. Company details
- 15.5.2. Financial outlook
- 15.5.3. Product summary
- 15.5.4. Recent developments
15.6. GE Healthcare
- 15.6.1. Company details
- 15.6.2. Financial outlook
- 15.6.3. Product summary
- 15.6.4. Recent developments
15.7. Roche Diagnostics
- 15.7.1. Company details
- 15.7.2. Financial outlook
- 15.7.3. Product summary
- 15.7.4. Recent developments
15.8. Qiagen
- 15.8.1. Company details
- 15.8.2. Financial outlook
- 15.8.3. Product summary
- 15.8.4. Recent developments
15.9. Others